EQS Newsfeed

Corpare News, Press, Analysis

Made with ❤ von BGFL
#BGFLapp * beta

EQS News is by far the most important platform for official company news. Boersengefluester.de combines the latest ad-hoc announcements or other company news from our database, meaningful share charts and other useful links from the BGFL data pool, thus creating added value for investors who prefer to obtain timely and meaningful information from the original source. Tip: You are also welcome to use our newsfeed focussing on the latest analyst research to round things off.

25.02.2026 06:25PM

Preliminary business figures for 2025

  Preliminary business figures for 2025   Einhell Germany AG (ISIN: DE 000A40ESU3), listed in the Prime Standard of Deutsche Börse AG, announces the following: The Einhell Group once again achieved record sales in the past financial year after presenting its preliminary business figures. Group revenue for 2025 amounts to EUR 1,157.7 million co [ … ]
25.02.2026 12:06PM

Westwing expands to the United Kingdom

Westwing expands to the United Kingdom Munich, 25 February 2026 // Westwing Group SE (“Westwing”), Europe‘s #1 in Beautiful Living e-commerce, announces its market entry into the United Kingdom. This expansion marks Westwing’s 23rd European market and serves as another important milestone in the third phase of its three-step value creation plan: Sc [ … ]
25.02.2026 11:00AM

Preliminary financial figures 2025 – IVU again on record course – special dividend proposed

Berlin, 25 February 2026 | IVU will achieve or exceed its targets in the 2025 financial year. The Executive Board and Supervisory Board will therefore propose a dividend increase and a special dividend to mark the 25th anniversary of the company's listing on the stock exchange to the Annual General Meeting. The preliminary results now available sh [ … ]
25.02.2026 08:00AM

Pentixapharm Receives FDA “Study May Proceed” Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program

  Pentixapharm Receives FDA “Study May Proceed” Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program U.S. Investigational New Drug (IND) applications for radiotheranostic pair PentixaFor and PentixaTher became active following completion of the FDA 30-day review period. Proposed phase I/II trial designed to confirm the suitab [ … ]
25.02.2026 07:30AM

Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds Aurase shows dual action on chronic wound debridement and healing SolasCure preparing fund raising for clinical phase 2b/3 Sequential growth forecaste [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
If desired, the news can be limited to certain indices (DAX, MDAX, etc.) or market segments (Prime Standard, General Standard, Scale, etc.).
Dataselect Tool Family
          EQS Newsfeed          
          Qualitätsjournalismus · Made in Germany © 2026          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 by Gereon Kruse #BGFL